| scholarly article | Q13442814 |
| P50 | author | Ka Fai To | Q99551275 |
| Nathalie Wong | Q114442539 | ||
| Yuen Piu Chan | Q117282530 | ||
| Pak Shing Kwan | Q117282532 | ||
| Kwok Wah Chan | Q117282533 | ||
| Paul Bo-San Lai | Q43682730 | ||
| P2093 | author name string | Xin-Yuan Guan | |
| Bo-Jian Zheng | |||
| Chung Mau Lo | |||
| Stephanie Ma | |||
| Kwan Ho Tang | |||
| Terence K Lee | |||
| Kwan Man | |||
| Irene Ng | |||
| Antonia Castilho | |||
| P2860 | cites work | Cancer statistics, 2009 | Q29547625 |
| DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal | Q29615487 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 694-707 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. | |
| P478 | volume | 7 |
| Q24629063 | 22q11.2 Distal Deletion Syndrome: Description of a New Case with Truncus Arteriosus Type 2 and Review |
| Q37334123 | 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin |
| Q98771514 | A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q36200984 | ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma. |
| Q37461452 | Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549 |
| Q36562175 | Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122. |
| Q36782633 | Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop |
| Q21245772 | An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells |
| Q33755766 | Apoptotic death of cancer stem cells for cancer therapy |
| Q34182315 | Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells |
| Q54211194 | Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma. |
| Q53687520 | Baicalein targets GTPase-mediated autophagy to eliminate liver tumor initiating stem cell-like cells resistant to mTORC1 inhibition. |
| Q37256772 | Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II. |
| Q38757074 | Biological and clinical significance of cancer stem cell plasticity |
| Q38045627 | Biology and clinical implications of CD133(+) liver cancer stem cells. |
| Q37873961 | Biology of hepatic cancer stem cells. |
| Q39024382 | Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. |
| Q38964120 | C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. |
| Q40744258 | C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. |
| Q50053330 | CD133 expression and α-fetoprotein levels define novel prognostic subtypes of HBV-associated hepatocellular carcinoma: A long-term follow-up analysis |
| Q39459026 | CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling |
| Q36170883 | CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells |
| Q35892134 | CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy |
| Q38922806 | CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? |
| Q27313878 | CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival |
| Q36982860 | CD133: a stem cell biomarker and beyond |
| Q35954464 | CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. |
| Q27022017 | Can nanomedicines kill cancer stem cells? |
| Q26737714 | Cancer Stem Cells in Human Gastrointestinal Cancer |
| Q37920789 | Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges |
| Q38540375 | Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q55223236 | Cancer stem cells of hepatocellular carcinoma. |
| Q38023238 | Cancer stem cells, microRNAs, and therapeutic strategies including natural products |
| Q90776672 | Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential |
| Q38984431 | Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line |
| Q38174864 | Cellular reprogramming and hepatocellular carcinoma development |
| Q33704244 | Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells. |
| Q35668771 | Chemokines and their receptors play important roles in the development of hepatocellular carcinoma |
| Q35841111 | Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study |
| Q34357073 | Clinical implications of cancer stem cell biology in hepatocellular carcinoma |
| Q39419867 | Clinical implications of microRNAs in liver cancer stem cells. |
| Q51742862 | Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. |
| Q92704085 | Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells |
| Q37536262 | Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patients |
| Q34373598 | Discovery of multi-dimensional modules by integrative analysis of cancer genomic data |
| Q39240497 | Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma |
| Q24600829 | Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma |
| Q35048411 | Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells |
| Q90733598 | Downregulation of microRNA-3934-5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1 |
| Q94562107 | Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma |
| Q38749763 | Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma. |
| Q38756588 | Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study |
| Q38156124 | Emerging role of microRNAs in cancer and cancer stem cells |
| Q41457379 | Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy |
| Q38058972 | Epigenetic alterations involved in cancer stem cell reprogramming |
| Q35741268 | Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer |
| Q88105265 | Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges |
| Q91473462 | Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer |
| Q35868092 | Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. |
| Q47422423 | Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis |
| Q39353165 | FOXM1 in Cancer: Interactions and Vulnerabilities |
| Q101564398 | Fate and functional roles of Prominin 1+ cells in liver injury and cancer |
| Q51151425 | Foxm1 controls a pro-stemness microRNA network in neural stem cells. |
| Q38102553 | Friend or foe: the role of microRNA in chemotherapy resistance |
| Q34674548 | G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinoma |
| Q37604978 | Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice |
| Q50286908 | H19 lncRNA regulates keratinocyte differentiation by targeting miR-130b-3p |
| Q38788971 | Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma |
| Q40766851 | Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell |
| Q58772807 | High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine |
| Q42590086 | Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFβ tumor suppressor signaling pathways |
| Q31068871 | Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus |
| Q38730296 | IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/- mice |
| Q39078029 | Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers |
| Q47151920 | Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1. |
| Q35005633 | Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma |
| Q35653328 | Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells |
| Q34983695 | Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells |
| Q35190239 | Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis. |
| Q55105236 | Large-scale discovery of previously undetected microRNAs specific to human liver. |
| Q41670848 | Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells |
| Q38241983 | Long noncoding RNAs in liver cancer: what we know in 2014. |
| Q33566650 | MTDH promotes glioma invasion through regulating miR-130b-ceRNAs |
| Q47821487 | Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. |
| Q41190434 | Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells |
| Q34039589 | MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo |
| Q35052873 | MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells |
| Q38963063 | MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. |
| Q39325786 | MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells |
| Q28658442 | MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma |
| Q38178272 | MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas |
| Q54256847 | MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection. |
| Q38185615 | MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. |
| Q57177537 | MicroRNA regulation of liver cancer stem cells |
| Q37549278 | MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected]. |
| Q35853951 | MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. |
| Q53125757 | MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells. |
| Q34685429 | MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma |
| Q38795326 | MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling |
| Q37722172 | MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer. |
| Q39531134 | MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML |
| Q38748118 | MicroRNAs and Cancer Drug Resistance |
| Q36116268 | MicroRNAs and cancer therapeutics |
| Q34717904 | MicroRNAs and liver disease. |
| Q26751780 | MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer |
| Q51793583 | MicroRNAs in liver disease. |
| Q38043263 | MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. |
| Q40536884 | MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters. |
| Q61818108 | MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q38948202 | Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT. |
| Q33756006 | Molecular biology of liver cancer stem cells |
| Q53221564 | Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs. |
| Q36993572 | Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. |
| Q92434894 | Mutual suppression between BHLHE40/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells |
| Q44811513 | Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma |
| Q38794563 | Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells |
| Q34285282 | Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes |
| Q55403266 | Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. |
| Q33716459 | Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis |
| Q47215507 | Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications |
| Q38885495 | Noncoding RNAs in Therapeutic Resistance of Cancer |
| Q36905769 | Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells |
| Q34940971 | Novel therapeutic strategies for targeting liver cancer stem cells |
| Q48273193 | Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. |
| Q35740040 | Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway |
| Q39019365 | Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma |
| Q41228828 | Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma |
| Q38831430 | PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells |
| Q34571496 | Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells |
| Q38712770 | Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL. |
| Q48238728 | Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma |
| Q39544347 | Prognostic relevance of miR-137 in patients with hepatocellular carcinoma. |
| Q64245227 | RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog |
| Q38552115 | Recent insights into hepatic cancer stem cells |
| Q37513688 | Regulation of stem cell populations by microRNAs |
| Q41773876 | Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. |
| Q38264776 | Role of miRNA in head and neck squamous cell carcinoma |
| Q27014034 | Role of microRNAs in hepatocellular carcinoma: a clinical perspective |
| Q38274949 | Role of microRNAs in maintaining cancer stem cells |
| Q37995020 | Role of stemness-related molecules in neuroblastoma |
| Q38875128 | Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells |
| Q47132613 | Roles of Tumor Microenvironment in Hepatocelluar Carcinoma. |
| Q35061623 | Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China |
| Q37309060 | Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. |
| Q92348105 | Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target |
| Q35090652 | Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers |
| Q42643718 | Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma |
| Q64272956 | Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma |
| Q28079205 | Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer |
| Q50053655 | Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC. |
| Q83600789 | TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p |
| Q90398809 | The Cancer Stem Cell in Hepatocellular Carcinoma |
| Q55423816 | The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells. |
| Q90227916 | The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma |
| Q38645695 | The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. |
| Q27005618 | The Role of microRNAs in Stemness of Cancer Stem Cells |
| Q26749450 | The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells |
| Q38178133 | The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment |
| Q38708772 | The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147+ breast cancer stem cells |
| Q39109959 | The evolving concept of liver cancer stem cells |
| Q27003050 | The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update |
| Q36536455 | The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. |
| Q38937821 | The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma |
| Q39319551 | The role of liver cancer stem cells in donor liver allocation for patients with hepatocellular carcinoma |
| Q38164571 | The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. |
| Q34355665 | Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells |
| Q34092485 | Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations |
| Q36839372 | Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis |
| Q59355189 | Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy |
| Q37034545 | Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. |
| Q27692697 | Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives. |
| Q37327695 | ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a. |
| Q41127938 | Zinc finger protein X-linked promotes expansion of EpCAM+ cancer stem-like cells in hepatocellular carcinoma |
| Q57295964 | iNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway |
| Q33661028 | miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma |
| Q40106559 | miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma |
| Q90365948 | miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features |
| Q58699670 | miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways |
| Q99608941 | miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A |
| Q42368111 | miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming |
| Q37410466 | miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma |
| Q51116863 | miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling. |
| Q38231531 | miRNA in hepatocellular carcinoma |
| Q34673760 | miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer |
| Q35912303 | miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. |
| Q55252304 | microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. |
Search more.